Consolidated Balance Sheet (Unaudited) - USD ($) $ in Thousands		Sep. 30, 2022	Dec. 31, 2021
Assets
Investments at fair value	[1],[2]	$ 104,455
Cash and cash equivalents		291,369
Interest receivable		918
Prepaid expenses and other assets		586
Total Assets		397,328
Liabilities
Debt (net of deferred financing costs of $2,493)	[3]	214,704
Management fees payable to affiliate		26
Incentive fees on net capital gains accrued to affiliate		47
Other payables to affiliate		759
Other liabilities		2,464
Total Liabilities		218,000
Commitments and contingencies (Note 7)
Net Assets
Common shares, $0.001 par value; unlimited shares authorized, 7,287,800 shares issued and outstanding		73
Additional paid-in capital		180,529
Accumulated net loss		(1,274)
Total Net Assets		179,328
Total Liabilities and Net Assets		$ 397,328
Net Asset Value Per Share		$ 24.61
Non-controlled, Non-affiliated Investments
Assets
Investments at fair value		$ 104,455

[1] In accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 820, Fair Value Measurements (“ASC Topic 820”), unless otherwise indicated, the fair values of all investments were determined using significant unobservable inputs and are considered Level 3 investments. See Note 5 for further information related to investments at fair value.

[2] Unless otherwise indicated, the Company’s portfolio companies are domiciled in the United States. Under the Investment Company Act of 1940, as amended (the “1940 Act”), the Company would “control” a portfolio company if the Company owned more than 25% of its outstanding voting securities and/or had the power to exercise control over the management or policies of such portfolio company. As of September 30, 2022, the Company does not “control” any of the portfolio companies.

[3] The carrying value of the Revolving Credit Facility is presented net deferred financing costs of $2.5 million.